ok- this was op’s call a while ago.
I believe, the most likely case moving forward with a treatment for CLBP is a $30m trial involving about 300 patients for 12 months duration . If investors don’t want to stick around that long...that’s their choice. I’m back( pun intended), but I will have something to say in the near future about management shortcomings...to say that they were fortunate to secure the backing of Surgecenter is a massive understatement..
Love your work OP
Reg
ok- this was op’s call a while ago. I believe, the most likely...
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |